Fluorometholone

규격

426-13-1CAS 번호

207-041-5EC 번호

(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-oneIUPAC 명칭

C22H29FO4화학식

376.5 g/mol분자량

fluorometholone; 426-13-1; Oxylone; Fluor-Op; FML Forte; Fluorometolona; Fluorometholonum; Fluorometolone; DTXSID7047435; 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione; Fluaton; (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; SV0CSG527L; NSC-33001; CHEBI:31625; NSC33001; DTXCID5027435; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-; Fluoro Ophtal; Isopto Flucon; Flucon, Isopto; Fluor Op; Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-6alpha-methyl-; PMS Fluorometholone; Fml fte; Fml-neo; (1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-5-one; (1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one; (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-3-one; RefChem:56898; C05AA06; D07AB06; D07XB04; D10AA01; S01BA07; S01CB05; fluorometholone ophthalmic suspension; 207-041-5; Flumetholon; Fluoromethalone; Fluormetholone; Cortilet; Delmeson; FML Liquifilm; Trilcin; NSC 33001; FML; Fluormetholon; U 8614; component of Neo-Oxylone; MFCD00056461; Fluorometholone (Standard); MLS000069537; MLS001076157; Fluormetholonum; SMR000058598; Fluorometolone [DCIT]; Neo-Oxylone; FML-S Liquifilm; (6alpha,11beta)-9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione; FML S.O.P.; Fluorometholonum [INN-Latin]; Fluorometolona [INN-Spanish]; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-; Oxylone (TN); Fluor-op (TN); Fml (TN); EINECS 207-041-5; UNII-SV0CSG527L; Fluorometholon; AI3-52813; FAOZLTXFLGPHNG-KNAQIMQKSA-N; NCGC00016442-01; CAS-426-13-1; Prestwick_227; 9-Fluoro-11-beta,17-dihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione; Fluorometholone [USP:INN:BAN:JAN]; Opera_ID_341; Prestwick0_000718; Prestwick1_000718; Prestwick2_000718; Prestwick3_000718; F0414; Fluorometholone, >=98%; Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17-dihydroxy-6-alpha-methyl-; SCHEMBL5051; FLUOROMETHOLONE [MI]; BSPBio_000935; FLUOROMETHOLONE [INN]; FLUOROMETHOLONE [JAN]; SPBio_002856; FLUOROMETHOLONE [VANDF]; BPBio1_001029; GTPL7079; orb1304332; orb3139676; FLUOROMETHOLONE [MART.]; CHEMBL1200600; FLUOROMETHOLONE [USP-RS]; FLUOROMETHOLONE [WHO-DD]; HY-B1893R; MSK2246; Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methyl-; Fluorometholone (JP18/USP/INN); GLXC-15335; HMS1570O17; HMS2097O17; HMS2234F16; HMS3714O17; HY-B1893; Tox21_110440; Tox21_302593; BDBM50103631; EBC-26852; FLUOROMETHOLONE [ORANGE BOOK]; MSK2246-100A; s5486; AKOS015895108; FML-S COMPONENT FLUOROMETHOLONE; MSK2246-1000A; Tox21_110440_1; AC-3520; CCG-220718; DB00324; FF23440; FLUOROMETHOLONE [USP MONOGRAPH]; NCGC00021575-03; NCGC00021575-05; NCGC00256631-01; (1R,3aS,3bS,5S,9aS,9bR,10S,11aS)-1-acetyl-9b-fluoro-1,10-dihydroxy-5,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; 21-Desoxy-9a-fluoro-6-methylprednisolone; AS-12363; NCI60_002886; SY075610; CS-0013955; CS-0694990; NS00007682; Progesterone, 17-dihydroxy-6.alpha.-methyl-; D01367; EN300-24430753; Q607349; SR-01000003019; Fluorometholone Solution in Acetonitrile, 1000ug/mL; Fluorometholone Solution in Acetonitrile, 100ug/mL; SR-01000003019-2; BRD-K64862097-001-03-9; BRD-K64862097-001-12-0; Fluorometholone, British Pharmacopoeia (BP) Reference Standard; Fluorometholone, United States Pharmacopeia (USP) Reference Standard; (6a,11b)-9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione; Pregna-1,20-dione, 9-fluoro-11.beta.,17-dihydroxy-6.alpha.-methyl-; Progesterone, 1-dehydro-9-fluoro-11.beta., 17-dihydroxy-6.alpha.-methyl-; (6|_,11|_)-9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione; Pregna-1,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6I+/-,11I(2))-; (1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one; 21-Desoxy-9|A-fluoro-6-methylprednisolone; (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; 6a-Methyl-9a-fluoro-1 1b,17a-dihydroxypregna-1,4-diene-3,20-dione11b,17a-dihydroxypregna-1,4-diene-3,20-dione; Pregna-1, 4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha., 11.beta.)-동의어